Americas COVID-19 Testing Market By Sample Type (Nasopharyngeal Swabs and Blood), By Test Type (SARS-CoV-2 Antigen, SARS-CoV-2 IgM/IgG Antibody, and Multiplex Real-time RT-PCR), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales Channel, Drug Store, and Diagnostic Laboratories), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Competitive Landscape
  • 1.6. Taxonomy
  • 1.7. Industry Voices
• 2. Market Overview
  • 2.1. Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Americas COVID-19 Testing Market Trends
  • 2.3. Technology Landscape
  • 2.4. Regulatory Framework
  • 2.5. Sustainability and ESG (Environmental, Social, Governance)
  • 2.6. Opportunity Map Analysis
  • 2.7. Opportunity Orbits
  • 2.8. PESTLE Analysis
  • 2.9. PORTER’S Five Force Analysis
  • 2.10. Drivers & Restraints Impact Analysis
  • 2.11. Value Chain Analysis
    • 2.11.1. List of Raw Materials Suppliers
    • 2.11.2. List of Americas COVID-19 Testing Manufacturers
    • 2.11.3. List of Dealer/Distributors
  • 2.12. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Americas COVID-19 Testing Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Americas COVID-19 Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Sample Type, 2020-2034
  • 3.3. Americas COVID-19 Testing Market Attractiveness Analysis, By Sample Type
    • 3.3.1. Nasopharyngeal Swabs
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Blood
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
  • 3.4. Americas COVID-19 Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Test Type, 2020-2034
  • 3.5. Americas COVID-19 Testing Market Attractiveness Analysis, By Test Type
    • 3.5.1. SARS-CoV-2 Antigen
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. SARS-CoV-2 IgM/IgG Antibody
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Multiplex Real-Time RT-PCR
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
  • 3.6. Americas COVID-19 Testing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 3.7. Americas COVID-19 Testing Market Attractiveness Analysis, By Distribution Channel
    • 3.7.1. Hospital Pharmacies
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Retail Pharmacies
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Online Sales Channel
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
    • 3.7.4. Drug Stores
      • 3.7.4.1. Insights
      • 3.7.4.2. Key Takeaways
    • 3.7.5. Diagnostic Laboratories
      • 3.7.5.1. Insights
      • 3.7.5.2. Key Takeaways
• 4. Competitive Landscape & Company Profiles
  • 4.1. Market Competition Scenario Analysis, By Company
    • 4.1.1. Key Takeaways
  • 4.2. Overview of Major Market Players
  • 4.3. Competitor Landscape
  • 4.4. Strategic Mapping
  • 4.5. Company Life Cycle Analysis
  • 4.6. Company Market Share Analysis
  • 4.7. Company Profiles
    • 4.7.1. Abbott Laboratories
      • 4.7.1.1. Company Details
      • 4.7.1.2. Business Overview
      • 4.7.1.3. Product Portfolio
      • 4.7.1.4. Financial Insights
      • 4.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.1.6. SWOT Analysis
      • 4.7.1.7. Geographic Footprint
    • 4.7.2. Roche
      • 4.7.2.1. Company Details
      • 4.7.2.2. Business Overview
      • 4.7.2.3. Product Portfolio
      • 4.7.2.4. Financial Insights
      • 4.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.2.6. SWOT Analysis
      • 4.7.2.7. Geographic Footprint
    • 4.7.3. Thermo Fisher Scientific, Inc
      • 4.7.3.1. Company Details
      • 4.7.3.2. Business Overview
      • 4.7.3.3. Product Portfolio
      • 4.7.3.4. Financial Insights
      • 4.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.3.6. SWOT Analysis
      • 4.7.3.7. Geographic Footprint
    • 4.7.4. Danaher (Cepheid)
      • 4.7.4.1. Company Details
      • 4.7.4.2. Business Overview
      • 4.7.4.3. Product Portfolio
      • 4.7.4.4. Financial Insights
      • 4.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.4.6. SWOT Analysis
      • 4.7.4.7. Geographic Footprint
    • 4.7.5. Becton Dickinson & Co
      • 4.7.5.1. Company Details
      • 4.7.5.2. Business Overview
      • 4.7.5.3. Product Portfolio
      • 4.7.5.4. Financial Insights
      • 4.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.5.6. SWOT Analysis
      • 4.7.5.7. Geographic Footprint
    • 4.7.6. bioMérieux SA
      • 4.7.6.1. Company Details
      • 4.7.6.2. Business Overview
      • 4.7.6.3. Product Portfolio
      • 4.7.6.4. Financial Insights
      • 4.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.6.6. SWOT Analysis
      • 4.7.6.7. Geographic Footprint
    • 4.7.7. QIAGEN N.V.
      • 4.7.7.1. Company Details
      • 4.7.7.2. Business Overview
      • 4.7.7.3. Product Portfolio
      • 4.7.7.4. Financial Insights
      • 4.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.7.6. SWOT Analysis
      • 4.7.7.7. Geographic Footprint
    • 4.7.8. Siemens Healthineers
      • 4.7.8.1. Company Details
      • 4.7.8.2. Business Overview
      • 4.7.8.3. Product Portfolio
      • 4.7.8.4. Financial Insights
      • 4.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.8.6. SWOT Analysis
      • 4.7.8.7. Geographic Footprint
• 5. Methodology and Data Source
  • 5.1. Methodology/Research Approach
  • 5.2. Market Size Estimation
  • 5.3. Market Breakdown and Data Triangulation
  • 5.4. Data Source
  • 5.5. Secondary Sources
  • 5.6. Primary Sources
  • 5.7. Appendix
  • 5.8. Disclaimer

List of Tables

• Table 1. Americas COVID-19 Testing Market Value (US$ Mn), By Sample Type, 2020-2034
• Table 2. Americas COVID-19 Testing Market Value (US$ Mn), By Test Type, 2020-2034
• Table 3. Americas COVID-19 Testing Market Value (US$ Mn), By Distribution Channel, 2020-2034

List of Figures

• Figure 1. Americas COVID-19 Testing Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Americas COVID-19 Testing Market Analysis, By Sample Type, 2020, 2024 and 2034
• Figure 5. Americas COVID-19 Testing Market Attractiveness Analysis, By Sample Type
• Figure 6. Americas COVID-19 Testing Market Analysis, By Test Type, 2020, 2024 and 2034
• Figure 7. Americas COVID-19 Testing Market Attractiveness Analysis, By Test Type
• Figure 8. Americas COVID-19 Testing Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 9. Americas COVID-19 Testing Market Attractiveness Analysis, By Distribution Channel